Newsletters
Since I’ve noticed that many newsletters end up in the recipient’s SPAM folder, I’ve created this page as a precaution where all newsletters will be published.
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- B7-H3 ADC YL201 Delivers Encouraging Results in Advanced mCRPC May 26, 2026
- Phase 1/2 Trial: Epigenetic KAT6 Inhibitor Plus Darolutamide in mCRPC May 26, 2026
- Newsletter 21/2026 May 24, 2026
- A-DREAM Trial Suggests Some Men with Metastatic Prostate Cancer May Stop Therapy Safely for a Time May 22, 2026
Newsletter 12/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This week the focus is on preclinical research. The fact that the AACR Annual Meeting 2026 is starting in less than a month means there are a lot of interesting new developments in the preclinical field. I’ll try to […]
Newsletter 11/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! Here we are again. We fall, we get back up, we gather our strength, and we move forward. Another week of encouraging news, my friends. Stay strong and fight on! As usual, we also have a podcast if you […]
Newsletter 10/2026
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! Another week full of interesting and promising clinical trials! The approaches are multiplying, and immunotherapies are advancing even for prostate cancer, which is beginning to respond. Stay strong and fight on! As usual, we also have a podcast if […]